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Background/aim: This study aims to investigate the relationship between gastric wall fat halo sign and potentially associated
cardiovascular disease (CVD) in thoracic computed tomography (CT).
Materials and methods: Between October 2020 and January 2021, 62 patients with gastric wall fat halo sign and 62 controls were
evaluated with thorax CT. Patient’s height, weight, body mass index (BMI), sex, age, comorbidities, laboratory parameters, diameters of
cardiac axes, aorta and pulmonary artery; aorta and coronary artery calcium scores were recorded for the two groups.
Results: No significant differences were found in sex, age, height, body weight or BMI between the two groups (p > 0.124). Patients with
gastric wall fat halo sign had significantly larger diameters of the ascending aorta, the descending aorta, the main pulmonary artery, the
right and left pulmonary arteries, and the short and long cardiac axes and a higher cardiothoracic ratio (CTR) than the control group
(p < 0.001). Additionally, the calcium scores of the ascending, arcus, and descending aortas and the coronary arteries were significantly
higher detected in patients group (p < 0.001). Patient group had significantly higher lipid profile, frequencies of diabetes mellitus (DM)
and hypertension (HT) than control group (p<0.026).
Conclusion: Patients with a gastric wall fat halo may show higher cardiovascular risk because of increased visceral fat tissue, vascular
diameters, CTR, heart sizes, presence of DM, HT, increased lipid profile and calcium scores.
Key words: Cardiovascular disease, computed tomography, gastric wall fat halo sign, obesity

1. Introduction
Despite
preventative
and
therapeutic
efforts,
cardiovascular diseases (CVDs), especially heart disease
and stroke, are prominent causes of mortality and
morbidity around the world [1]. The main risk factors and
pathological mechanisms resulting in CVD can be traced
back to childhood [2]. There are several controllable and
uncontrollable risk factors for CVD, such as male sex,
family history, old age, smoking, hypertension (HT),
physical inactivity, hypercholesterolemia, diabetes mellitus
(DM) and obesity [3].
The unfavorable consequences of overweight and
obesity have increased worldwide and can be seen
beginning in childhood [4]. Obesity is thought to be an
independent risk factor for CVD, and increased body mass
index (BMI) facilitates the development of comorbidities
that contribute to CVD [5,6]. The generally preferred
anthropometric technique to evaluate relative weight
and classify obesity is BMI, which is the ratio of total
body weight to height squared. Additionally, obesity is

a remarkably heterogeneous condition, and visceral fat
tissue has been revealed to be more deeply related to CVD
than subcutaneous or total fat tissue [7,8].
A fat halo sign refers to linear fat accumulation in the
submucosal layer of the gastric, colonic and small bowel
wall [9]. The fat halo sign can be evaluated with CT and
magnetic resonance imaging (MRI). Fat halo sign is
detected as fat accumulation with attenuation of <−10
Hounsfield units (HUs) on CT images and an increased fat
signal in MRI [9,10]. The fat halo in the intestinal wall was
first associated with chronic inflammatory bowel diseases,
but it can also be commonly detected in overweight
people, especially those with increased visceral fat tissue
[11,12]. Additionally, fat halo sign can be observed in
approximately 21% of patients who underwent computed
tomography (CT) examinations [11].
There are only a few studies on gastric wall fat halo
sign [13–15]. To the best of our knowledge, no study has
investigated the gastric wall fat halo sign as a risk factor
for CVD. This paper aims to investigate the relationship
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between gastric wall fat halo sign and potentially associated
CVD based on thorax CT.
2. Materials and methods
2.1. Participants
Between October 2020 and January 2021, data from 104
patients who underwent thorax CT for clinical suspicion
of COVID-19 infection and with no signs of infection in
CT, negative COVID-19 PCR test, normal serum hs-CRP
levels, and had gastric wall fat halo sign were prospectively
recorded. Then, unenhanced thorax CT examinations in
which the field of view (FOV) comprised all of the stomach
were selected for study. Patients with contrast enhanced
thorax CT (n = 21), chronic inflammatory bowel disease
history (n = 3), not enough FOV comprising all of the
stomach (n = 7), age younger than 18 years (n = 2), chronic
renal failure (n = 3) and implanted coronary artery stents
in which calcium score could not be measured (n = 6)
were not included in the study. Therefore, 62 patients were
included in the final study (Figure 1).
For the age- and sex-matched control group, 62
consecutive patients who underwent unenhanced thorax
CT for clinical suspicion of COVID-19 infection and no
signs of infection in CT, negative COVID-19 PCR test,
normal serum hs-CRP levels and had no gastric wall
fat halo sign were selected from the clinical database.
Demographic and clinical data including the patients’
age, gender, height (m), body weight (kg), smoking status,
comorbidities such as DM, HT and laboratory parameters
such as urea, creatinine, lipid panels were noted for
the patient and control groups from the medical files.
Additionally, BMI (kg/m2) was calculated as the ratio of
total body weight to height squared for both groups. This
study was approved by the Institutional Ethics Committee
(approval number 2021 / 17–01).

Figure 1. Patient flow chart.
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2.2. CT protocol
The thorax CT examinations were performed with the
participants in the supine position, and the patients were
scanned from the lung apices to the adrenal gland level
during a breath hold at the end of inspiration with using
120 slices (Siemens Somatom Sensation, Forchheim,
Germany). All patients were examined using the standard
scanning protocol without intravenous contrast agent. The
CT protocol was as follows: 120 kVp, tube current of 150–
165 mAs, maximum 2.5 mm collimation, slice thickness of
1.5 mm and rotation time of 0.5 s. Then, the images were
reconstructed into multiplanar reformations.
2.3. Analysis of CT images
The CT images were reevaluated by two radiologists
without knowing laboratory findings and the results
were obtained by consensus. The images were transferred
to the Syngo workstation (Siemens Medical Solutions).
Linear fat accumulation in the submucosal layer of the
gastric wall with attenuation of <−10 Hounsfield units
(HUs) was described as a gastric wall fat halo sign (Figure
2). The measurements of the outer wall of the ascending
aorta, the descending aorta, the main pulmonary artery,
and the right and left pulmonary arteries were recorded
in the axial plane at the level of the pulmonary artery
bifurcation (Figure 3). After detecting the axial slice level
that represented the four-chamber view of the heart, the
long and short cardiac axes and the maximum transverse
thoracic diameters were measured at the same level ( 4).
Then, the cardiothoracic ratio (CTR) was calculated as
the ratio of the long diameter of the cardiac axis to the
maximum transverse thoracic diameter. The calcification
of the ascending, arcus, and descending aortas and
coronary artery calcification were quantified with the
previously defined method [16]. A region of interest
(ROI) was positioned manually on the calcification of the
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ascending, arcus, and descending aortas and the coronary
arteries. After selecting the total number of pixels over 130
HUs, the calcium score was computed with the software.
2.4. Statistical analysis
All of the data were analyzed using the Statistical Package
for the Social Sciences (SPSS 13.0 Statistical Software,
SPSS Inc., Chicago, IL, USA) and the MedCalc package
of Statistical Software version 16.8 (MedCalc Software
bvba, Ostend, Belgium). Descriptive statistics, including
the means and ranges, were calculated for numeric
variables. The Kolmogorov–Smirnov test was used
to identify deviations from normal distribution and
appropriate tests were selected accordingly. Additionally,
the Student’s t-test was used to the compare numeric
data with normal distribution. The Mann-Whitney U test
was used to compare the numeric data with not normal
distribution. Additionally, chi-squared tests were used
to compare the categorical variables including smoking
statues, HT and DM. To identify variables associated with
age, the multivariate regression analysis was conducted to
elucidate the predictors. Collinearity diagnostics analysis
was performed to identify the potential mutilcollinearity
between variables. A p value of less than 0.05 was
considered to indicate a significant difference.
3. Results
In this study, 62 patients (45 male, 17 female) with gastric
wall fat halo sign and 62 control patients (42 male, 20

female) were analyzed. The mean ages of the patient
and control groups were 63.5 ± 8.1 and 61.8 ± 7.8 years,
respectively. The mean height (m), body weight (kg) and
BMI (kg/m2) of the patient and control groups were 1.62 ±
0.1 m and 1.62 ± 0.1 m; 80.8 ± 13.4 kg and 77.2 ± 12.5 kg;
and 30.6 ± 4.9 and 29.4 ± 4.8 kg/m2, respectively. There was
no statistically significant difference in sex or the mean
values of age, height, body weight or BMI between the two
groups (p > 0.05).
The demographic and CT findings of patients and
control groups are presented in Tables 1 and 2. Patients
with gastric wall fat halo sign had significantly larger
diameters of the ascending aorta, the descending aorta, the
main pulmonary artery, and the right and left pulmonary
arteries than the control group (p < 0.001). Although the
short and long diameters of the cardiac axis and CTR were
observed to be significantly higher in patients with gastric
wall fat halo sign (p < 0.001), no statistically significant
difference was detected in the transverse thoracic diameter
between the two groups (p = 0.998). Additionally, the
calcium scores of the ascending, arcus, and descending
aortas (Figure 5A) and coronary arteries (Figure 5B) were
significantly higher in patients with gastric wall fat halo
sign than in patients without a gastric wall fat halo sign (p
< 0.001).
Patients with gastric wall fat halo sign had significantly
higher LDL, triglyceride, total cholesterol and lower HDL
than the control group (p < 0.026). Also, no statistically

Table 1. Patient characteristics.
Gastric wall fat halo sign

p value

Present (n = 62)

Absent (n = 62)

Age (y)

63.5 ± 8.1

61.8 ± 7.8

0.214a

Sex (Male/Female)

45/17

42/20

0.556b

Height (cm)

162.3 ± 10.0

162.8 ± 8.9

0.779a

Weight (kg)

80.8 ± 13.4

77.2 ± 12.5

0.124a

Body mass index (kg/m2)

30.6 ± 4.9

29.4 ± 4.8

0.143a

Hypertension

32

16

0.009b

Diabetes mellitus

32

17

0.016b

Smoking

10

7

0.443b

Blood urea nitrogen

34.4 ± 15.6

33.2 ± 11.6

0.651a

Creatinine

1.0 ± 0.3

1.0 ± 0.2

0.286a

HDL- Cholesterol (mg/dL)

43.0 ± 10.5

48.1 ± 9.4

0.023a

LDL- Cholesterol (mg/dL)

119.8 ± 26.8

102.9 ± 34.8

0.026a

Triglyceride (mg/dL)

213.5 ± 88.3

156.1 ± 81.9

0.015a

Total cholesterol (mg/dL)

204.4 ± 22.8

183.1 ± 42.7

0.022a

Note: Values are expressed as mean ± SD, a: Student’s t-test, b: chi-squared test.
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Table 2. CT findings of patients and control groups.
Gastric wall fat halo sign

p value

Present (n = 62)

Absent (n = 62)

Ascending aorta

38.5 ± 3.2

32.8 ± 3.9

<0.001a

Descending aorta

29.4 ± 2.9

24.2 ± 2.8

<0.001a

Main

29.7 ± 4.4

24.4 ± 3.6

<0.001a

Right

22.4 ± 3.7

18.1 ± 3.1

<0.001a

Left

22.3 ± 2.9

17.9 ± 2.8

<0.001a

Long cardiac diameter (mm)

13.1 ± 1.9

11.2 ± 1.2

<0.001a

Short cardiac diameter (mm)

10.5 ± 1.1

9.4 ± 1.0

<0.001a

The maximum transverse thoracic diameter (mm)

25.2 ± 2.4

25.2 ± 2.1

0.998a

Cardiothoracic ratio

0.52 ± 0.08

0.44 ± 0.06

<0.001a

Ascending aorta

0 (0–795)

0 (0–431)

<0.001b

Arcus aorta

237.5 (0–5064)

7 (0–1145)

<0.001b

Descending aorta

76.5 (0–5958)

0 (0–1145)

<0.001b

Total

417.0 (0–11817)

10 (0–2827)

<0.001b

Coronary arteries

51.5 (0–851)

0 (0–387)

<0.001b

Aortic diameter (mm)

Pulmonary artery diameter (mm)

Calcium score

Note: Values are expressed as mean ± SD or median (min-max), a: Student’s t-test, b: Mann–Whitney U test.

Figure 2. 43 year-old man with back pain.
Unenhanced thorax CT image represents thin
linear fatty infiltration in submucosal layer of
gastric wall with attenuation value <−10 HU.

Figure 3. 43 year-old man with cough complaint. The
measurements of the ascending aorta, the descending
aorta, the main pulmonary artery, and the right and left
pulmonary arteries were recorded in the axial plane at the
level of the pulmonary artery bifurcation.

significant difference was found in mean values of
creatinine and BUN (p > 0.286). Although, there was no
statistically significant difference in the frequencies of
smoking between two groups (p = 0.443), patients with
gastric wall fat halo sign had significantly higher DM and
HT than without ones (p < 0.016).

The results of multivariate regression analyses
performed between age and diameters of the aorta and
pulmonary artery, CTR, the calcium scores of aortas and
coronary arteries are shown in Table 3. There was no
significant association with the primary outcome within
the multivariate regression.
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Table 3. Regression coefcients of age and variables.
Unstandardized coefficients

Standardized
coefficients

t

Beta

Std. error

Beta

Ascending aorta

0.361

0.241

0.206

1.500

Descending aorta

0.055

0.344

0.024

Main pulmonary artery

0.077

0.300

0.044

Right pulmonary artery

0.115

0.490

Left pulmonary artery

0.153

0.474

Cardiothoracic ratio

–6.914

Ascending aorta calcium score
Arcus aorta calcium score

p value

Collinearity statistics
Tolerance

VIF

0.137

0.413

2.424

0.159

0.874

0.344

2.911

0.255

0.799

0.259

3.866

0.057

0.235

0.815

0.129

7.741

0.066

0.324

0.747

0.190

5.275

9.992

–0.075

–0.692

0.490

0.667

1.499

0.002

0.012

0.020

0.136

0.892

0.349

2.865

–0.002

0.004

-0.166

-0.490

0.625

0.067

14.823

Descending aorta calcium score

0.002

0.002

0.170

0.992

0.323

0.274

3.648

Total

0.001

0.002

0.230

0.603

0.548

0.054

18.675

Coronary arteries calcium score

0.010

0.008

0.166

1.360

0.177

0.524

1.910

Figure 4. 51 year-old man with headache. The
measurements of the long and short cardiac axes
and the maximum transverse thoracic diameter were
obtained at the axial slice level that represented the
maximum size of the heart.

Figure 5. 59-year-old man with gastric wall fat halo sign. Unenhanced sagittal CT image
shows extensive calcific atherosclerotic plaques in aorta (A) and unenhanced axial CT
image shows extensive calcific atherosclerotic plaques in coronary arteries (B).
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4. Discussion
In this study, the relationship between gastric wall fat halo
sign and CVD was investigated in thorax CT and gastric wall
fat halo sign might be detected in patients with increased
aorta and pulmonary artery diameters and calcium scores.
Although there are several studies of the fat halo sign
in the gastrointestinal tract, there are few studies involving
the fat halo sign in the gastric wall [10–19]. To the best
of our knowledge, this is the first study investigating
the relationship between gastric wall fat halo sign and
associated CVD based on thorax CT.
The fat halo sign was first thought to indicate the
presence of inflammatory bowel disease. However, fat
halo sign can be seen especially in overweight people.
Additionally, gastric wall fat halo sign can be observed
in patients without gastrointestinal disease and with
increased visceral fat tissue [13,14]. After fat is stored in
normal adipose tissues, free fatty acids are discharged into
the blood [20]. The fat halo sign could be related to an
increase in the blood concentration of free fatty acids and
could be an indicator of excessive fat accumulation [20].
An increase in the plasma concentration of free fatty
acids (FFA) is a quite often complication of visceral fat depot
and overexposure of hepatic and extrahepatic tissues to
FFA can cause disturbances in insulin metabolism which is
resulted with insulin resistance and DM [21]. Also, obesity
is related with higher LDL cholesterol, total cholesterol,
triglyceride and lower HDL cholesterol plasma levels. It
is reported that small dense LDL is more atherogenic in
patients who have hyperlipidemia and insulin resistance
associated with visceral obesity [22]. Moreover, visceral
obesity leads to hypertension with complex interconnected
relationship between insulin resistance, hyperlipidemia and
hypertension [21]. This study showed that the frequencies
of DM and HT in patients with gastric wall fat halo sign
were significantly higher than control group whereas there
was no significant relationship in smoking. Furthermore,
patients with gastric wall fat halo sign had significantly
higher LDL, triglyceride, total cholesterol and lower
HDL levels than the control group. Inside this association
the connection as how gastric wall fat halo sign which is
consequence of visceral obesity leads to hyperlipidemia,
DM and HT may be found.
The aorta and pulmonary artery diameters can be
easily evaluated through chest CT. This study revealed that
patients with gastric wall fat halo sign had significantly
higher ascending, descending aorta and main, right and left
pulmonary artery diameters than those without fat halo sign.
One of the causes of these is visceral obesity. The increase in
diameters associated with visceral obesity could be related
to the process of adaptation to hypertension, increased
blood volume and underlying structural or functional
aortic abnormalities [23]. Additionally, visceral obesity can

1174

stimulate vascular aging, resulting in future cardiovascular
events [8]. Visceral obesity and gastric wall fat halo sign are
associated with each other, so increased aorta and pulmonary
artery diameters may be related to this relationship.
Obesity is connected with most CVDs, such as
coronary heart disease, hypertension and heart failure
[24]. In particular, visceral adipose tissue is hormonally
active tissue that contributes to vascular inflammation
by producing adipokines and is a risk factor for mortality
and CVD [25]. Additionally, obesity is related to some
hemodynamic changes, such as increased cardiac output,
diastolic filling pressure, left ventricle hypertrophy and
ventricular dilatation [26]. The CTR is usually used to
evaluate cardiomegaly in chest radiography, cardiomegaly
indicating underlying CVD, is evidenced by hypertrophy
or dilation of the heart [27]. Despite a lack of significant
difference in the transverse thoracic diameter, patients
with gastric wall fat halo sign had significantly higher
short and long diameters of the cardiac axis and CTRs
than the control group. These results may be related to
cardiovascular changes caused by visceral adipose tissue.
Atherosclerosis is a major cause of death and morbidity
in industrialized societies due to its association with
cardiovascular events and peripheral vascular disease.
Atherosclerosis has different stages, and calcification
indicates advanced atherosclerotic lesions [28]. Although
the cause of vascular calcification is not fully understood,
inflammation, dysregulated metabolism, and osteogenesis
are some processes associated with vascular calcification
[29]. Thoracic aortic calcification represents a systemic
atherosclerotic burden and results in an increased risk of
CVDs [30]. Visceral fat tissue is an endocrine organ that can
produce atherogenic agents. Additionally, this condition
can induce vascular aging resulting in an increased risk
of CVDs, hypertension and calcified atherosclerotic
plaques [31]. It has been reported that the risk of aortic
atherosclerosis increases as the amount of visceral fat
tissue increases [32]. This study showed that patients with
gastric wall fat halo sign had significantly higher calcium
scores in the ascending, arcus, and descending aortas than
patients without fat halo sign.
Coronary artery disease (CAD), caused by
atherosclerosis, is a main cause of morbidity and
mortality worldwide, so the early diagnosis of subclinical
atherosclerosis is crucial for preventing CAD. Similar to
thoracic aortic calcification, obesity is an independent
risk factor for atherosclerosis and coronary artery
calcification [33]. The calcium score of coronary arteries
indicates the burden of atherosclerotic plaque in arteries
and is a helpful, noninvasive method for the assessment
of subclinical atherosclerosis in asymptomatic patients
[34]. Additionally, the calcium score of coronary arteries
is connected with cardiovascular events and obesity [34].
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This study revealed that higher calcium scores of coronary
arteries were detected in patients with gastric wall fat halo
sign related to visceral obesity.
This study has a number of limitations. Atherosclerotic
plaques have different components which are lipid-rich,
fibrous, and calcified areas and can be often intermixed.
We evaluated only calcified plaques with CT attenuation
values above 130 HU. Since our CT images were obtained
without intravenous contrast medium administration, the
soft and intermediate plaques could not be analyzed in our
study. The second limitation was that the CT images were
evaluated based on a consensus, and we did not evaluate
the inter- or intraobserver variability in this study. The
third limitation was that participants in the patient and
control groups did not undergo abdominal CT imaging,
so visceral fat tissue measurement could not be performed
in this study. Fourth, the number of patients was also
relatively small. Fifth, data could not be correlated with
echocardiographic findings.
5. Conclusion
The gastric wall fat halo results from excessive fat
accumulation and can be observed in overweight

people, especially those with increased visceral fat tissue.
Additionally, patients with a gastric wall fat halo have
higher cardiovascular risk because of higher frequencies
of hyperlipidemia, DM, HT and increased vascular
diameters, CTR, heart sizes and calcium scores. Presence
of gastric wall fat halo on routine thorax or abdominal CT
images may be a warning sign for cardiovascular diseases.
However, extensive studies with larger populations are
needed to clearly confirm the relationships of gastric wall
fat halo sign with cardiovascular diseases.
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